Moreover, we showed that LINC00152 levels are higher in tumors compared to normal tissues (Supplementary Fig. S2A, B) and that its higher expression is associated with worse overall survival (Supplementary Fig. S2C, D) also in patients with other tumors, e.g., hepatocellular carcinoma and lung adenocarcinoma. Here, CYTOR is linked to hepatocellular carcinoma.